about
Reduction in synaptic GABA release contributes to target-selective elevation of PVN neuronal activity in rats with myocardial infarctionBeta blockers in heart failure: a comparison of a vasodilating beta blocker with metoprolol.AT(1)-receptor blockade and sympathetic neurotransmission in cardiovascular disease.Altered astrocyte glutamate transporter regulation of hypothalamic neurosecretory neurons in heart failure rats.Carvedilol in the treatment of elderly patients with chronic heart failure.Angiotensin-converting enzyme 2 overexpression improves central nitric oxide-mediated sympathetic outflow in chronic heart failure.Enhanced NMDA receptor-mediated intracellular calcium signaling in magnocellular neurosecretory neurons in heart failure rats.Regulation of central angiotensin type 1 receptors and sympathetic outflow in heart failure.Coupling between respiratory and sympathetic activities as a novel mechanism underpinning neurogenic hypertension.Endocrine-Autonomic Linkages.The Potential Role of Catheter-Based Renal Sympathetic Denervation in Chronic and End-Stage Kidney Disease.Baroreceptor control of the circulation in man. An update.Neurohumoral activation in heart failure: role of paraventricular nucleus.Clinical relevance of heart rate variability.Altered thermoregulatory responses in heart failure patients exercising in the heat.Effect of adrenergic blockers, carvedilol, prazosin, metoprolol and combination of prazosin and metoprolol on paracetamol-induced hepatotoxicity in rabbits.Impaired neuronal and vascular responses to angiotensin II in a rabbit congestive heart failure model.
P2860
Q33994934-9EFFCCEB-6A72-4178-81F9-3B7DCE4FA39BQ35366259-97BC1956-C266-4623-B2D9-BD61DDFD7CB5Q35837657-7CEE1D5E-FB7F-4EED-A2BC-3DD9707B851AQ36178516-2F781A0E-6AD0-4773-B4DA-4C56AC9A848FQ36892905-5AF4B42A-CD92-45E8-9EC5-C5F010063D24Q37079211-3907C06A-DCA9-46BC-9442-B7F7314147CEQ37323514-62E57394-1DE3-4C83-9361-59FB5E538B09Q37430939-53A504B5-0F4B-4781-B43B-95C2E3754857Q37858914-128EF6B3-CB04-4314-96B6-D0825198BB7DQ38542455-C9EEA50C-B7DF-4E32-ADC6-24A5754F4F0CQ38689037-D73073BF-FA71-42DA-A5F2-4904E1177342Q40516333-9F838410-570C-4451-B3E0-ACE0341D4917Q41183395-20BA2862-6ED5-4C2F-9E61-1EFECBE365A3Q41349287-D6451AEE-5E15-43B8-8BA1-FFF9973223F2Q42367421-E1580256-8AA7-4C48-B687-72258F03951FQ42582976-C36A39DA-802F-4ECA-8D58-B363FE96FBFEQ44702101-8A44F8B5-A687-4DAE-ADEF-53BFE3A8A8C3
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Sympathetic activation in congestive heart failure.
@en
Sympathetic activation in congestive heart failure.
@nl
type
label
Sympathetic activation in congestive heart failure.
@en
Sympathetic activation in congestive heart failure.
@nl
prefLabel
Sympathetic activation in congestive heart failure.
@en
Sympathetic activation in congestive heart failure.
@nl
P356
P1476
Sympathetic activation in congestive heart failure.
@en
P2093
P356
10.1093/EURHEARTJ/11.SUPPL_A.3
P478
11 Suppl A
P577
1990-04-01T00:00:00Z